BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27714961)

  • 1. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations.
    Tryon R; Zierhut H; MacMillan ML; Wagner JE
    Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel frame-shift deletion in FANCF gene causing autosomal recessive Fanconi anemia: a case report.
    Zareifar S; Dastsooz H; Shahriari M; Faghihi MA; Shekarkhar G; Bordbar M; Zekavat OR; Shakibazad N
    BMC Med Genet; 2019 Jul; 20(1):122. PubMed ID: 31288759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The causes of Fanconi anemia in South Asia and the Middle East: A case series and review of the literature.
    Thompson AS; Saba N; McReynolds LJ; Munir S; Ahmed P; Sajjad S; Jones K; Yeager M; Donovan FX; Chandrasekharappa SC; Alter BP; Savage SA; Rehman S
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1693. PubMed ID: 33960719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
    Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
    Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
    Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
    Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis on phenotype and genetic basis of Chinese Fanconi anemia patients: dismal outcomes call for nationwide studies.
    Nie D; Zhang J; Wang F; Zhang W; Liu L; Chen X; Zhang Y; Cao P; Xiong M; Wang T; Wu P; Ma X; Tian W; Wang M; Chen KN; Liu H
    BMC Med Genet; 2020 Jun; 21(1):118. PubMed ID: 32487094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair.
    van de Vrugt HJ; Harmsen T; Riepsaame J; Alexantya G; van Mil SE; de Vries Y; Bin Ali R; Huijbers IJ; Dorsman JC; Wolthuis RMF; Te Riele H
    Sci Rep; 2019 Jan; 9(1):768. PubMed ID: 30683899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thinking of VACTERL-H? Rule out Fanconi Anemia according to PHENOS.
    Alter BP; Giri N
    Am J Med Genet A; 2016 Jun; 170(6):1520-4. PubMed ID: 27028275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.
    Yabe M; Koike T; Ohtsubo K; Imai E; Morimoto T; Takakura H; Koh K; Yoshida K; Ogawa S; Ito E; Okuno Y; Muramatsu H; Kojima S; Matsuo K; Mori M; Hira A; Takata M; Yabe H
    Ann Hematol; 2019 Feb; 98(2):271-280. PubMed ID: 30368588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
    Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
    Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia.
    Tischkowitz M; Ameziane N; Waisfisz Q; De Winter JP; Harris R; Taniguchi T; D'Andrea A; Hodgson SV; Mathew CG; Joenje H
    Br J Haematol; 2003 Nov; 123(3):469-71. PubMed ID: 14617007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.
    Bouchlaka C; Abdelhak S; Amouri A; Ben Abid H; Hadiji S; Frikha M; Ben Othman T; Amri F; Ayadi H; Hachicha M; Rebaï A; Saad A; Dellagi K;
    J Hum Genet; 2003; 48(7):352-61. PubMed ID: 12827451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway.
    Wang Z; Li M; Lu S; Zhang Y; Wang H
    Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current clinical management of Fanconi anemia.
    Smith AR; Wagner JE
    Expert Rev Hematol; 2012 Oct; 5(5):513-22. PubMed ID: 23146055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.
    Catucci I; Osorio A; Arver B; Neidhardt G; Bogliolo M; Zanardi F; Riboni M; Minardi S; Pujol R; Azzollini J; Peissel B; Manoukian S; De Vecchi G; Casola S; Hauke J; Richters L; Rhiem K; Schmutzler RK; Wallander K; Törngren T; Borg Å; Radice P; Surrallés J; Hahnen E; Ehrencrona H; Kvist A; Benitez J; Peterlongo P
    Genet Med; 2018 Apr; 20(4):452-457. PubMed ID: 28837162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.